Transcriptomic and pathway analyses of cystic fibrosis lung disease identify candidate therapeutic targets and small molecules
Abstract
Details
- Title: Subtitle
- Transcriptomic and pathway analyses of cystic fibrosis lung disease identify candidate therapeutic targets and small molecules
- Creators
- Matthew Daniel Strub
- Contributors
- Paul B McCray Jr (Advisor)Christopher M Adams (Committee Member)Robert C Piper (Committee Member)Todd E Scheetz (Committee Member)David A Stoltz (Committee Member)
- Resource Type
- Dissertation
- Degree Awarded
- Doctor of Philosophy (PhD), University of Iowa
- Degree in
- Genetics
- Date degree season
- Spring 2020
- DOI
- 10.17077/etd.005406
- Publisher
- University of Iowa
- Number of pages
- xx, 272 pages
- Copyright
- Copyright 2020 Matthew Daniel Strub
- Language
- English
- Description illustrations
- color illustrations
- Description bibliographic
- Includes bibliographical references (pages 237-272).
- Public Abstract (ETD)
Cystic fibrosis (CF) is a lethal disorder caused by mutations in the CFTR gene. CF causes severe and progressive lung disease characterized by persistent bacterial infections and bronchiectasis and affects roughly 1 in 2,000 people of European ancestry. The most common CFTR mutation, termed ∆F508, results in a misfolded protein that is degraded before trafficking to the cell membrane where it would normally function as an anion channel. However, if ∆F508-CFTR reaches the cell membrane, it retains partial channel function, resulting in less severe disease phenotypes. As ~90% of people with CF have at least one ∆F508 allele, a prominent goal in CF research is to rescue the trafficking and function of this mutant protein. My thesis work aims to identify small molecules that restore function to the mutant CFTR protein and to better characterize genes that interact with CFTR during its biogenesis. Such “CFTR interactome” genes could serve as therapeutic targets. Here, I describe the discovery of XL147, a small molecule that restores partial function to mutated CFTR. Additionally, I present several in silico analyses that uncover novel pathways related to CFTR trafficking and function, as well as several genes that could be targeted for therapeutic purposes.
- Academic Unit
- Interdisciplinary Graduate Program in Genetics
- Record Identifier
- 9983966298202771